home.social

#keytruda — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #keytruda, aggregated by home.social.

fetched live
  1. The trial enrolled 1,137 high-risk patients with stage 2b to 4 #melanoma that had been surgically removed.

    Volunteers were randomized to receive up to 9 doses of #Keytruda plus ⁠the personalized #vaccine or Keytruda alone for about one year. The companies said no new safety signals have emerged in the trial. Previous studies showed the most common side effects were fatigue, pain at the injection site & chills [better than dying!].

    #PublicHealth #health #science #medicine #MedicalBreakthrough

  2. A personalized #mRNA #cancer #vaccine combined with the #immunotherapy #Keytruda succeeded in a late-stage trial for the deadly skin cancer #melanoma, its makers said Wednesday, potentially opening up a new way of treating the #disease.

    The study is ongoing, but interim results found the treatment, #intismeran, met both its primary target of reducing cancer recurrence & its secondary ⁠goal of keeping cancers from spreading to other parts of the body.

    #PublicHealth #health #science #medicine

  3. Ivermectin and Fenbendazole for Female Reproductive System: 30 Case Reports (March 2026 Edition) Introduction Cancers of the female reproductive system, including ovarian, endometrial (uterine), an...

    #case #studies #cervical #cancer #keytruda #ovarian #cancer #repurposed #drugs #uterine #cancer

    Origin | Interest | Match
  4. Ivermectin and Fenbendazole for Female Reproductive System: 25 Case Reports (January 2026) Introduction Cancers of the female reproductive system, including ovarian, endometrial (uterine), and cerv...

    #case #studies #cervical #cancer #keytruda #ovarian #cancer #repurposed #drugs #uterine #cancer

    Origin | Interest | Match
  5. Faut réduire la #securitesociale et fliquer les médecins qui prescrivent des arrêts maladies aux non-politiciens/miliardaires car ça coûte trop cher :

    quechoisir.org/enquete-medicam

    Labo #MSD #Novartis

    = pénurie de médicaments 'anciens' génériques/vieux brevêt cf #paracetamol

    #sante #politique #economie #corruption #pembrolizumab #keytruda #monopole #zolgensma #vyndaqel #business

  6. Dostarlimab vs Pembrolizumab: Difference between Jemperli and Keytruda (2024) Key Takeaways Dostarlimab plus chemotherapy showed improved overall survival compared to pembrolizumab in advanced NSCL...

    #cancer #colorectal #cancer #dostarlimab #immunotherapy #keytruda #lung #cancer #pharma

    Origin | Interest | Match
  7. Keytruda strikes out again in endometrial cancer with phase III flop—Novo inks $600M deal with Metaphore to develop next-gen obesity drugs —Takeda Pharma to restructure after annual profit slump --bit.ly/w28kSd #merck #keytruda #endometrialcancer #clinicaltrials #novonordisk #obesity #drugdevelopment #takeda #restructuring #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  8. Pembrolizumab, sold under the brand name #Keytruda, targets and blocks a specific protein on the surface of certain immune cells that then seek out and destroy the cancerous cells.
    In England it is offered to those with #triple-#negative #breast #cancer, one of the most aggressive forms of the disease, which accounts for about 15% of cases.
    However, new findings from a global trial suggest it could be effective when used more widely

    theguardian.com/society/2024/m

  9. "#Moderna hofft auf #Hautkrebs-Impfstoff ab 2025

    Der US-Pharmakonzern Moderna hofft, 2025 einen Impfstoff gegen schwarzen Hautkrebs auf den Markt bringen zu können. Neue Ergebnisse einer klinischen #Studie sind vielversprechend."

    #Immuntherapie #Onkologie #Antikörpermedikament #Keytruda

    zdf.de/nachrichten/wirtschaft/

  10. Phase 2b clinical trial from Moderna & Merck using an #mRNA #cancer #vaccine + #Keytruda for a #melanoma #vaccine for stage III & IV disease reducing the risk of recurrence or death by 44% compared to Keytruda alone. Serious treatment-related adverse events occurred in 14.4% of patients who received the combination arm compared to Keytruda alone.

    Phase 3 trial is planned for 2023.

    investors.modernatx.com/news/n